These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36778584)

  • 21. Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry.
    Friedman DJ; Pierre D; Wang Y; Gambone L; Koutras C; Segawa C; Farb A; Vemulapalli S; Varosy PD; Masoudi FA; Lansky A; Curtis JP; Freeman JV
    Am Heart J; 2022 Dec; 254():102-111. PubMed ID: 36007567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated deep learning design for medical image classification by health-care professionals with no coding experience: a feasibility study.
    Faes L; Wagner SK; Fu DJ; Liu X; Korot E; Ledsam JR; Back T; Chopra R; Pontikos N; Kern C; Moraes G; Schmid MK; Sim D; Balaskas K; Bachmann LM; Denniston AK; Keane PA
    Lancet Digit Health; 2019 Sep; 1(5):e232-e242. PubMed ID: 33323271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.
    Kuzma J; Najmaie P; Larson J
    J Law Med Ethics; 2009; 37(4):546-86. PubMed ID: 20122100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital board oversight of quality and patient safety: a narrative review and synthesis of recent empirical research.
    Millar R; Mannion R; Freeman T; Davies HT
    Milbank Q; 2013 Dec; 91(4):738-70. PubMed ID: 24320168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From single biobanks to international networks: developing e-governance.
    Kaye J
    Hum Genet; 2011 Sep; 130(3):377-82. PubMed ID: 21785980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers to Effective Deliberation in Clinical Research Oversight.
    Wenner DM
    HEC Forum; 2016 Sep; 28(3):245-59. PubMed ID: 26613717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Governance frameworks for COVID-19 research ethics review and oversight in Latin America: an exploratory study.
    Palmero A; Carracedo S; Cabrera N; Bianchini A
    BMC Med Ethics; 2021 Nov; 22(1):147. PubMed ID: 34742278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A content-based literature recommendation system for datasets to improve data reusability - A case study on Gene Expression Omnibus (GEO) datasets.
    Patra BG; Maroufy V; Soltanalizadeh B; Deng N; Zheng WJ; Roberts K; Wu H
    J Biomed Inform; 2020 Apr; 104():103399. PubMed ID: 32151769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-approval monitoring and oversight of U.S.-initiated human subjects research in resource-constrained countries.
    Brown B; Kinsler J; Folayan MO; Allen K; Cáceres CF
    J Bioeth Inq; 2014 Jun; 11(2):119-23. PubMed ID: 24839155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy oversight: lessons for nanobiotechnology.
    Wolf SM; Gupta R; Kohlhepp P
    J Law Med Ethics; 2009; 37(4):659-84. PubMed ID: 20122108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The views of quality improvement professionals and comparative effectiveness researchers on ethics, IRBs, and oversight.
    Whicher D; Kass N; Saghai Y; Faden R; Tunis S; Pronovost P
    J Empir Res Hum Res Ethics; 2015 Apr; 10(2):132-44. PubMed ID: 25742674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic Biology in the FDA Realm: Toward Productive Oversight Assessment.
    Fatehi L; Hall RF
    Food Drug Law J; 2015; 70(2):339-69, iii-iv. PubMed ID: 26302603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Authority and the Future of Consent in Population-Level Biomedical Research.
    Sheehan M; Thompson R; Fistein J; Davies J; Dunn M; Parker M; Savulescu J; Woods K
    Public Health Ethics; 2019 Nov; 12(3):225-236. PubMed ID: 32082417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.
    Fatehi L; Wolf SM; McCullough J; Hall R; Lawrenz F; Kahn JP; Jones C; Campbell SA; Dresser RS; Erdman AG; Haynes CL; Hoerr RA; Hogle LF; Keane MA; Khushf G; King NM; Kokkoli E; Marchant G; Maynard AD; Philbert M; Ramachandran G; Siegel RA; Wickline S
    J Law Med Ethics; 2012; 40(4):716-50. PubMed ID: 23289677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in Completely Automated Vowel Analysis for Sociophonetics: Using End-to-End Speech Recognition Systems With DARLA.
    Coto-Solano R; Stanford JN; Reddy SK
    Front Artif Intell; 2021; 4():662097. PubMed ID: 34632373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products Discovery.
    van Santen JA; Jacob G; Singh AL; Aniebok V; Balunas MJ; Bunsko D; Neto FC; Castaño-Espriu L; Chang C; Clark TN; Cleary Little JL; Delgadillo DA; Dorrestein PC; Duncan KR; Egan JM; Galey MM; Haeckl FPJ; Hua A; Hughes AH; Iskakova D; Khadilkar A; Lee JH; Lee S; LeGrow N; Liu DY; Macho JM; McCaughey CS; Medema MH; Neupane RP; O'Donnell TJ; Paula JS; Sanchez LM; Shaikh AF; Soldatou S; Terlouw BR; Tran TA; Valentine M; van der Hooft JJJ; Vo DA; Wang M; Wilson D; Zink KE; Linington RG
    ACS Cent Sci; 2019 Nov; 5(11):1824-1833. PubMed ID: 31807684
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.